Cargando…

The first World Health Organization International Standard for infliximab products: A step towards maintaining harmonized biological activity

Due to the increase in the number of infliximab products, the need for global harmonization of the bioactivity of this monoclonal antibody was recognized by the World Health Organization (WHO). In response, the National Institute for Biological Standards and Control (NIBSC) developed the first inter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Metcalfe, Clive, Dougall, Thomas, Bird, Chris, Rigsby, Peter, Behr-Gross, Marie-Emmanuelle, Wadhwa, Meenu, study, participants of the
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343779/ https://www.ncbi.nlm.nih.gov/pubmed/30395763 http://dx.doi.org/10.1080/19420862.2018.1532766

Ejemplares similares

The First WHO International Standard for Harmonizing the Biological Activity of Bevacizumab
por: Jia, Haiyan, et al.
Publicado: (2021)

Establishment of the first international standard for PEGylated granulocyte colony stimulating factor (PEG-G-CSF): Report of an international collaborative study
por: Wadhwa, Meenu, et al.
Publicado: (2015)

The First WHO International Standard for Adalimumab: Dual Role in Bioactivity and Therapeutic Drug Monitoring
por: Wadhwa, Meenu, et al.
Publicado: (2021)

Harmonization of Zika neutralization assays by using the WHO International Standard for anti-Zika virus antibody
por: Mattiuzzo, Giada, et al.
Publicado: (2019)

IL-27 Promotes Proliferation of Human Leukemic Cell Lines Through the MAPK/ERK Signaling Pathway and Suppresses Sensitivity to Chemotherapeutic Drugs
por: Jia, Haiyan, et al.
Publicado: (2016)

International standards for monoclonal antibodies to support pre- and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximab
por: Prior, Sandra, et al.
Publicado: (2017)

Establishment of the World Health Organization First International Standard for Factor XII, Plasma, Human
por: Wilmot, Helen V., et al.
Publicado: (2018)

Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human
por: Wilmot, Helen, et al.
Publicado: (2017)

Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study
por: McDonald, Jacqueline U., et al.
Publicado: (2018)

A Cost-Utility Analysis of Switching from Reference to Biosimilar Infliximab Compared to Maintaining Reference Infliximab in Adult Patients with Crohn’s Disease
por: Hughes, Avery, et al.
Publicado: (2020)

World Health Organization International Standard to Harmonize Assays for Detection of Hepatitis E Virus RNA
por: Baylis, Sally A., et al.
Publicado: (2013)

Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data
por: Guerra Veloz, María Fernanda, et al.
Publicado: (2019)

Effect of Standardized Infliximab Dose Rounding on an Outpatient Infusion Center
por: Park, Jiyeon Joy, et al.
Publicado: (2018)

Remission of Cap Polyposis Maintained for More Than Three Years after Infliximab Treatment
por: Kim, Eun Sun, et al.
Publicado: (2009)

A descriptive analysis of real-world treatment patterns of innovator (Remicade(®)) and biosimilar infliximab in an infliximab-naïve Turkish population
por: Yazici, Yusuf, et al.
Publicado: (2018)

Analysis of real-world treatment patterns in a matched rheumatology population that continued innovator infliximab therapy or switched to biosimilar infliximab
por: Yazici, Yusuf, et al.
Publicado: (2018)

Implementation and Evaluation of a Standard Operating Procedure for Pediatric Infliximab Infusions
por: Kelly, Maureen M., et al.
Publicado: (2019)

The impact of thioredoxin reduction of allosteric disulfide bonds on the therapeutic potential of monoclonal antibodies
por: Gurjar, Shalom A., et al.
Publicado: (2019)

Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis
por: Sakkat, Abdullah, et al.
Publicado: (2022)

Serum Infliximab Cutoff trough Level Values for Maintaining Hematological Remission in Pediatric Inflammatory Bowel Disease
por: Choi, So Yoon, et al.
Publicado: (2019)

Rethinking Assessment: Harmonizing practices and standards across Europe
por: PepsiCo (UK, Ireland & South Africa), Katie McNab
Publicado: (2013)

Time to harmonize national ambient air quality standards
por: Kutlar Joss, Meltem, et al.
Publicado: (2017)

Harmonization and standardization of nucleus pulposus cell extraction and culture methods
por: Basatvat, Shaghayegh, et al.
Publicado: (2023)

Biological markers: maintaining standards
Publicado: (2000)

The evolution of applied harmonic analysis: models of the real world
por: Prestini, Elena
Publicado: (2016)

The evolution of applied harmonic analysis: models of the real world
por: Prestini, Elena
Publicado: (2004)

Infliximab for Crohn’s Disease: More Than 13 Years of Real-world Experience
por: Lichtenstein, Gary R, et al.
Publicado: (2018)

Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab Reintroduction
por: Normatov, Inessa, et al.
Publicado: (2021)

Impact of Formulation Choices on the Freeze-Drying of an Interleukin-6 Reference Material
por: Matejtschuk, Paul, et al.
Publicado: (2022)

Behçet's syndrome treated with infliximab, which caused a palmoplantar pustulosis, subsequently maintained on low-dose etanercept
por: Tresh, Amani, et al.
Publicado: (2012)

Infusion reaction to infliximab biosimilar after transitioning from infliximab
por: Kashlan, Reem, et al.
Publicado: (2020)

Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases
por: Ducourau, Emilie, et al.
Publicado: (2011)

Harmonic balance for nonlinear vibration problems
por: Krack, Malte, et al.
Publicado: (2019)

Sharing all types of clinical data and harmonizing journal standards
por: Barbui, Corrado
Publicado: (2016)

Enriching Personalized Endometrial Cancer Research with the Harmonization of Biobanking Standards
por: Adishesh, Meera, et al.
Publicado: (2019)

Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab
por: Fitzgerald, Timothy, et al.
Publicado: (2021)

Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
por: Subedi, Smriti, et al.
Publicado: (2019)

Harmonizing the interpretation of genetic variants across the world: the Malaysian experience
por: Nik Hassan, Nik Norliza, et al.
Publicado: (2016)

A Map of the Initiatives That Harmonize Patient Cohorts Across the World
por: Rodríguez-Laso, Ángel, et al.
Publicado: (2021)

The European Hematology Exam: The Next Step toward the Harmonization of Hematology Training in Europe
por: Navarro, José-Tomás, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ht0apfh84r1jr4mbs5dje0s5fv